Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial

Autor: Barakat, Mark R., Brown, David, Hu, Allen, Khurana, Rahul N., Marcus, Dennis, Pearlman, Joel, Wykoff, Charles C., Kapik, Barry, Ciulla, Thomas
Zdroj: In Ophthalmology Science January-February 2025 5(1)
Databáze: ScienceDirect